<DOC>
	<DOCNO>NCT01658150</DOCNO>
	<brief_summary>The purpose study evaluate use drug isradipine cognitive enhancement patient diagnose schizophrenia schizoaffective disorder .</brief_summary>
	<brief_title>Evaluating Isradipine Cognitive Enhancement Schizophrenia Schizoaffective Disorder</brief_title>
	<detailed_description>The purpose study evaluate use drug isradipine cognitive enhancement patient diagnose schizophrenia schizoaffective disorder . Incomplete treatment response common disorder . While medication effective treat positive symptom , symptom disorder often leave partially treat ( cognitive impairment negative symptom ) . This study begin address medication isradipine might help treat cognitive problem associate schizophrenia schizoaffective disorder . Isradipine medication act block specific type receptor brain call calcium channel . It currently approve FDA hypertension .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Isradipine</mesh_term>
	<criteria>Age 1860 DSMIV schizophrenia schizoaffective disorder diagnosis Residual phase illness criterion meet screen baseline define item score equal less 4 Brief Psychiatric Rating Scale ( BPRS ) hallucinatory behavior , unusual thought content , conceptual disorganization item Hamilton Rating Scale Depression ( HRSD ) equal less 12 Baseline Clinician Administered Scale Mania ( CARSM ) score less 5 Simpson Angus Scale ( SAS ) total score equal le 6 Treatment least one two stablydosed secondgeneration antipsychotic medication ( clozapine ) equal great 2 month change plan 4week study period History CNS trauma , neurological disorder , ADHD , mental retardation , learn disability , nonschizophrenic cause cognitive impairment DSMIV diagnosis substance abuse/dependence within 3 month Pregnant woman woman childbearing age use medically accept mean contraception Women breastfeed Active , unstable medical problem may interfere cognition Current treatment hypertension Uncontrolled hypertension Any drug know interact isradipine History GI strictures History heart disease Abnormal lab ECG screen Significant suicidal ideation baseline ( HRSD item 3 &gt; 2 ) ECT treatment within 12 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Cognition</keyword>
	<keyword>Schizophrenia</keyword>
	<keyword>Schizoaffective disorder</keyword>
</DOC>